DarioHealth Corp.

Last updated September 27, 2026

Organization details

Legal name
DarioHealth Corp.
Ownership
Public
Status
Active
Headquarters country
Israel
Ticker symbol
DRIO
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001533998

Board of directors

Chief executives

Erez Raphael · Chief Executive Officer
Dates unknown

Board connections

5 of this board's directors also sit on 6 other boards.

Network of DarioHealth Corp.'s board connections Citius Oncology Inc. Citius Oncology Inc. Citius Pharmaceuticals Inc. Citius Pharmaceuticals... Indaptus Therapeutics Inc. Indaptus Therapeutics... Lucid Diagnostics Inc. Lucid Diagnostics Inc. P3 Health Partners Inc. P3 Health Partners Inc... VivoSim Labs Inc. VivoSim Labs Inc. Adam K. Stern Adam K. Stern Dennis M. Mcgrath Dennis M. Mcgrath Dennis Matheis Dennis Matheis Hila Karah Hila Karah Lawrence B. Leisure Lawrence B. Leisure DarioHealth Corp.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Feb 24, 2025 Jon H. Kaplan Director Grant or award +30,000 — —
Nov 12, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.91 $4,550
Sep 11, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.80 $4,000
Sep 10, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.84 $4,200
Sep 9, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.80 $4,000
Sep 6, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.84 $4,200
Sep 5, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.82 $4,100
Aug 27, 2024 Erez Raphael Director, Officer (Chief Executive Officer) Open-market purchase +5,000 $0.88 $4,400
Aug 23, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.95 $4,750
Aug 22, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.95 $4,750
Aug 21, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.93 $4,650
Aug 21, 2024 Erez Raphael Director, Officer (Chief Executive Officer) Open-market purchase +5,000 $0.95 $4,750
Aug 20, 2024 Erez Raphael Director, Officer (Chief Executive Officer) Open-market purchase +5,000 $0.93 $4,650
Aug 20, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.94 $4,700
Aug 19, 2024 Nelson Steven Charles Officer (Chief Commercial Officer) Open-market purchase +5,000 $0.92 $4,600

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.